Proceedings of the Korean Society of Toxicology Conference (한국독성학회:학술대회논문집)
- 2002.11b
- /
- Pages.178-179
- /
- 2002
Investigation of autoimmunogenic potential of GX-12, a New anti-HIV DNA Vaccine, by popliteal lymph node assay and autoantibody induction
- Kang, Kyung-Koo (Research Laboratories, Dong-A Pharm. Co. Ltd.) ;
- Park, Min-Seul (Research Laboratories, Dong-A Pharm. Co. Ltd.) ;
- Baik, Dae-Hyun (Research Laboratories, Dong-A Pharm. Co. Ltd.) ;
- Lee, Dong-Sup (Research Laboratories, Dong-A Pharm. Co. Ltd.) ;
- Park, Jae-Hun (Research Laboratories, Dong-A Pharm. Co. Ltd.) ;
-
Ahn, Byoung-Ok
(Research Laboratories, Dong-A Pharm. Co. Ltd.)
;
- Kim, Won-Bae (Research Laboratories, Dong-A Pharm. Co. Ltd.)
- Published : 2002.11.01
Abstract
GX-12 is a naked DNA vaccine developed by Dong-A Pharmaceutical Company, Green Cross Company and Genexine for the treatment of HIV infection. GX-12 consists of four separate plasmids. This study was performed to investigate the autoimmunogenic potential of GX-12 using primary and secondary PLNA method, and to examine the induction of autoantibodies in mice immunized with GX-12.(omitted)